A clinical trial led by Newcastle University shows that the drug, idebenone (Catena®), improved the vision and perception of color in patients with Leber's Hereditary Optic Neuropathy (LHON). The inherited condition means patients, who can see normally, lose the sight in one eye then within 3 to 6 months lose the sight in their other eye.
To see more details, visit http://www.sciencedaily.com/releases/2011/07/110725202243.htm